通过AMPK/PGC-1α信号通路增强线粒体能量代谢,高素减轻心肌缺血再输伤
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。通过AMPK/ PGC-1α通路改善线粒体功能和减少氧化应激,保护心脏免受再输伤后的损伤.
科学领域
- 心脏病学
- 分子生物学
- 生物化学
背景情况
- 尽管恢复了血液流动,心肌缺血再输损伤 (MIRI) 导致了显著的心脏损伤,可能导致心力衰竭.
- 了解MIRI的机制对于开发有效的治疗策略至关重要.
研究的目的
- 在MIRI小鼠模型中研究Hypericin (Hyp) 的心脏保护作用.
- 阐明潜在的分子机制,特别关注线粒体功能和氧化应激.
主要方法
- 分别在老鼠和H9C2细胞中建立了MIRI和低氧/再氧化 (H/R) 模型.
- 用于评估其对心脏和心肌细胞功能,线粒体能量代谢和相关分子通路的影响.
- 技术包括组织学染色,心声学测试,ELISA,蛋白质组学,分子对接和西部涂抹.
主要成果
- 在MIRI小鼠中,高素显著降低了心肌梗塞的大小,改善了心脏功能.
- 主要通过缓解线粒体功能障碍和氧化应激,增加了心肌细胞活力和减少了细胞损伤.
- 这些效应通过腺单酸激活蛋白激酶 (AMPK) / Peroxisome增殖器激活受体 γ 协同激活器1-α (PGC-1α) 信号通路进行介导.
结论
- 在大鼠中,高素显著地对MIRI产生心脏保护作用.
- Hyp调节AMPK/ PGC-1α通路,增强线粒体能量代谢并减少氧化应激.
- 这些发现表明Hypericin是缓解MIRI诱导心脏损伤的潜在治疗剂.
相关概念视频
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...